PAX6 and lung carcinoma: The overexpression of SLUG and SNAIL in lung cancer cell lines with epidermal growth factor receptor (EGFR) mutation induces resistance against gefitinibThe PAX6-ZEB2 axis promotes cisplatin resistance and metastasis in NSCLC via the P13K/AKT signaling pathway